Back
Aligos Therapeutics Vs. Haemonetics Industry Stock Comparison
Buy
67
ALGS
Aligos Therapeutics
Last Price:
19.46
Seasonality Move:
0%
Buy
84
HAE
Haemonetics
Last Price:
90.82
Seasonality Move:
4.35%
Buy
67
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $19.46. The Score for ALGS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
84
Haemonetics (HAE)
is a Buy
Is Haemonetics a Buy, Sell or Hold?
- The current Haemonetics [HAE] share price is $90.75. The Score for HAE is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- HAE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $19.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
HAE Stock Price Chart
What is Haemonetics's stock price today?
-
The Haemonetics share price today is $90.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HAE is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.16 | Buy |
Relative Strength Index (14 RSI): | 84.86 | Buy |
Chaikin Money Flow: | 368752 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.36 - 13.62) | Buy |
Bollinger Bands (100): | (8.5 - 14.24) | Buy |
HAE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.02 | Buy |
Relative Strength Index (14 RSI): | 72.57 | Buy |
Chaikin Money Flow: | -649588 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.31 - 85.25) | Buy |
Bollinger Bands (100): | (73.5 - 86.58) | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.76 | Buy |
20-day SMA: | 10.65 | Buy |
50-day SMA: | 10.25 | Buy |
200-day SMA: | 15.3 | Buy |
8-day EMA: | 15.07 | Buy |
20-day EMA: | 12.01 | Buy |
50-day EMA: | 10.93 | Buy |
200-day EMA: | 14.51 | Buy |
HAE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.8 | Buy |
20-day SMA: | 79.08 | Buy |
50-day SMA: | 77.2 | Buy |
200-day SMA: | 81.73 | Buy |
8-day EMA: | 87.24 | Buy |
20-day EMA: | 81.87 | Buy |
50-day EMA: | 79.23 | Buy |
200-day EMA: | 81.38 | Buy |
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Haemonetics Earnings Growth & HAE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.63 per share.
Aligos Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Haemonetics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |